MIR5684

Across TCGA pan-cancer cohorts, MIR5684 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MIR5684 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher MIR5684 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR5684 expression acts as an unfavorable survival marker, although some lineages such as PAAD and SKCM show a favorable association.

TGCT, UCEC, and LUAD are the cancer types where MIR5684 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Tertile	II,III,IV	0.339	0.955	<.001	108	view →
UCEC	DFS	Tertile	All	0.808	0.909	.001	90	view →
LUAD	DFS	Quartile	IV	0.300	0.836	<.001	42	view →
PAAD	DFS	Tertile	All	0.424	0.242	.019	36	view →
PRAD	DFS	Tertile	All	0.792	0.905	.001	36	view →
SKCM	OS	Tertile	II,III,IV	0.647	0.272	.003	30	view →
CHOL	DFS	Median	All	0.669	0.268	.003	29	view →
OV	DFS	Tertile	IV	0.273	0.533	.001	26	view →
READ	OS	Tertile	III,IV	0.370	0.715	.033	24	view →
BRCA	OS	Tertile	III,IV	0.832	0.420	.002	21	view →
LIHC	OS	Tertile	III,IV	0.270	0.732	.021	18	view →
KIRC	DFS	Quartile	III,IV	0.291	0.534	.006	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MIR5684–TGCT (DFS)

Open the TGCT breakdown →